Plain-English translation of NCT07125235 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
The reSTART study is testing a new approach to help men living with HIV who use stimulants stay on track with their HIV medications and reduce stimulant use. The program combines a mobile app focused on building positive emotions, home-based urine tests to track medication adherence, and one-on-one motivational counseling. The goal is to help people with HIV achieve better viral suppression (meaning lower levels of the virus in their body) and improve their overall health.
Stimulant use can make it harder for people with HIV to take their medications regularly, which allows the virus to multiply and can undermine efforts to end the HIV epidemic in the U.S. This study is designed to test whether a multi-part approach—combining technology, self-monitoring, and counseling—can help overcome these barriers.
You likely qualify if…
You likely don't qualify if…
If you join this study, you'll attend a baseline meeting where a counselor will teach you how to use the home urine test kit and introduce you to the mobile app. Half of participants will receive the full reSTART program (the app, home testing supplies, and motivational support), while the other half will receive standard HIV care. Over the study period, you'll use the home urine test to check your medication adherence, receive motivational messages and feedback through the app, and complete periodic blood tests to measure your viral load. You'll also provide a small hair sample to confirm stimulant use.
AI-generated summary from trial data · Jun 14, 2026 · Not medical advice
United States